|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Biohaven Pharmaceutical Holding Co Ltd. (BHVN)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-12-03 Sale |
2018-12-06 4:26 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
40,000 | $41.95 | $1,678,000 | 1,156,002 (Direct Indirect) |
View |
| 2018-06-08 Sale(A) |
2018-06-20 9:29 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Chief Medical Officer |
76,692 | $36.36 | $2,788,707 | 316,283 (Indirect) |
View |
| 2018-06-15 Sale |
2018-06-19 4:43 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP |
12,500 | $40.02 | $500,250 | 25,000 (Direct) |
View |
| 2018-06-08 Sale |
2018-06-12 4:12 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Chief Medical Officer |
104,155 | $36.33 | $3,784,303 | 569,057 (Indirect) |
View |
| 2018-06-05 Sale |
2018-06-07 4:29 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Chief Medical Officer |
25,845 | $36.01 | $930,714 | 574,600 (Indirect) |
View |
| 2018-06-04 Sale |
2018-06-06 4:19 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
89,216 | $35.25 | $3,145,112 | 1,245,765 (Direct Indirect) |
View |
| 2018-05-30 Sale |
2018-06-01 5:29 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
110,784 | $35.03 | $3,881,056 | 1,395,160 (Direct Indirect) |
View |
| 2018-05-30 Sale |
2018-06-01 5:26 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad CEO |
50,000 | $35.02 | $1,750,900 | 549,259 (Indirect) |
View |
| 2018-05-30 Sale |
2018-05-30 6:02 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James CFO |
5,000 | $35 | $175,000 | 17,500 (Direct) |
View |
| 2018-05-10 Sale |
2018-05-14 5:11 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Chief Medical Officer |
35,000 | $26.82 | $938,706 | 576,380 (Indirect) |
View |
| 2018-05-07 Sale |
2018-05-09 4:53 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James CFO |
2,500 | $27.67 | $69,175 | 0 (Direct) |
View |
| 2018-04-10 Sale |
2018-04-12 5:02 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Chief Medical Officer |
35,000 | $24.66 | $863,132 | 585,740 (Indirect) |
View |
| 2018-03-12 Sale |
2018-03-14 5:05 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Chief Medical Officer |
35,000 | $30.11 | $1,053,929 | 590,590 (Indirect) |
View |
| 2018-03-01 Sale |
2018-03-05 4:31 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP |
5,000 | $32.87 | $164,344 | 37,500 (Direct) |
View |
| 2018-02-21 Sale |
2018-02-23 5:52 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James CFO |
538 | $29.6 | $15,925 | 3,038 (Direct) |
View |
| 2018-02-12 Sale |
2018-02-14 4:31 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Chief Medical Officer |
35,000 | $30.42 | $1,064,576 | 601,636 (Indirect) |
View |
| 2018-02-01 Sale |
2018-02-02 6:18 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP |
5,000 | $32.78 | $163,900 | 42,500 (Direct) |
View |
| 2018-01-31 Sale |
2018-02-02 6:17 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
50,000 | $33.71 | $1,685,352 | 2,516,701 (Direct) |
View |
| 2018-01-23 Sale |
2018-01-25 7:28 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
16,000 | $32.79 | $524,640 | 2,525,101 (Direct) |
View |
| 2018-01-19 Sale(A) |
2018-01-25 4:13 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | PORTAGE BIOTECH Inc former 10% owner |
59,396 | $31.31 | $1,859,406 | 78,771 (Direct) |
View |
| 2018-01-19 Sale(M) |
2018-01-24 7:01 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | PORTAGE BIOTECH Inc former 10% owner |
59,396 | $23.34 | $1,386,312 | 78,771 (Direct) |
View |
| 2018-01-22 Sale |
2018-01-24 7:00 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James CFO |
10,000 | $32.5 | $325,000 | 21,962 (Direct) |
View |
| 2018-01-19 Sale |
2018-01-23 6:57 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
49,000 | $30.76 | $1,507,459 | 2,583,289 (Direct) |
View |
| 2018-01-16 Sale |
2018-01-18 6:57 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
128,058 | $26.95 | $3,451,297 | 1,487,027 (Direct Indirect) |
View |
| 2018-01-16 Sale |
2018-01-18 6:37 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
40,000 | $26.52 | $1,060,800 | 2,590,101 (Direct) |
View |
| 2018-01-10 Sale |
2018-01-12 7:00 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
121,942 | $26.78 | $3,265,537 | 1,276,131 (Indirect) |
View |
| 2018-01-10 Sale |
2018-01-12 6:59 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Berman Robert Chief Medical Officer |
35,000 | $27.52 | $963,133 | 606,055 (Indirect) |
View |
| 2018-01-03 Sale(A) |
2018-01-11 11:06 am |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | PORTAGE BIOTECH Inc 10% Owner |
4,350 | $28.62 | $124,504 | 6,301,500 (Direct) |
View |
| 2018-01-05 Sale |
2018-01-09 6:23 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | PORTAGE BIOTECH Inc 10% Owner |
84,881 | $30.06 | $2,551,573 | 6,278,504 (Direct) |
View |
| 2018-01-03 Sale |
2018-01-05 8:05 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
50,000 | $28.71 | $1,435,528 | 1,187,275 (Direct) |
View |
| 2018-01-03 Sale |
2018-01-05 10:29 am |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | PORTAGE BIOTECH Inc 10% Owner |
4,350 | $28.62 | $124,504 | 124,371 (Direct) |
View |
(A) Indicate amendment filing.
(M) Indicate average unit share price adjusted based on the original filings.
(M) Indicate average unit share price adjusted based on the original filings.
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-09-07 Option Award |
2018-09-11 4:19 pm |
N/A 2028-09-06 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Repella Robert Director |
36,000 | $35.5 | 36,000 (Direct) |
View |
| 2018-06-15 Exercise |
2018-06-19 4:43 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP |
12,500 | $0.61 | 25,000 (Direct) |
View |
| 2018-06-15 Exercise |
2018-06-19 4:43 pm |
N/A 2024-11-25 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP |
12,500 | $0.61 | 25,000 (Direct) |
View |
| 2018-05-30 Exercise |
2018-05-30 6:02 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James CFO |
5,000 | $0.61 | 17,500 (Direct) |
View |
| 2018-05-30 Exercise |
2018-05-30 6:02 pm |
N/A 2024-11-25 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James CFO |
5,000 | $0.61 | 17,500 (Direct) |
View |
| 2017-11-09 Exercise |
2018-05-11 4:40 pm |
N/A 2024-11-25 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James CFO |
8,400 | $0.61 | 32,500 (Direct) |
View |
| 2018-05-01 Option Award |
2018-05-03 5:25 pm |
N/A 2028-04-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
18,000 | $28.76 | 18,000 (Direct) |
View |
| 2018-05-01 Option Award |
2018-05-03 5:24 pm |
N/A 2028-04-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
18,000 | $28.76 | 18,000 (Direct) |
View |
| 2018-05-01 Option Award |
2018-05-03 5:23 pm |
N/A 2028-04-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
18,000 | $28.76 | 18,000 (Direct) |
View |
| 2018-05-01 Option Award |
2018-05-03 5:22 pm |
N/A 2028-04-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director |
18,000 | $28.76 | 18,000 (Direct) |
View |
| 2018-05-01 Option Award |
2018-05-03 5:21 pm |
N/A 2028-04-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Cha Albert Director |
18,000 | $28.76 | 18,000 (Direct) |
View |
| 2018-05-01 Option Award |
2018-05-03 5:20 pm |
N/A 2028-04-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | AGUIAR ERIC Director |
18,000 | $28.76 | 18,000 (Direct) |
View |
| 2018-03-14 Option Award |
2018-03-15 6:20 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Cha Albert Director |
72,727 | $27.5 | 2,049,545 (Indirect) |
View |
| 2018-03-01 Exercise |
2018-03-05 4:31 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP |
5,000 | $0.61 | 37,500 (Direct) |
View |
| 2018-03-01 Exercise |
2018-03-05 4:31 pm |
N/A 2024-11-25 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP |
5,000 | $0.61 | 37,500 (Direct) |
View |
| 2018-02-01 Exercise |
2018-02-02 6:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP |
5,000 | $0.61 | 42,500 (Direct) |
View |
| 2018-02-01 Exercise |
2018-02-02 6:18 pm |
N/A 2024-11-25 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly VP |
5,000 | $0.61 | 42,500 (Direct) |
View |
| 2018-01-22 Exercise |
2018-01-24 7:00 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James CFO |
10,000 | $0.61 | 21,962 (Direct) |
View |
| 2018-01-22 Disposition |
2018-01-24 7:00 pm |
N/A 2024-11-25 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James CFO |
10,000 | $0.61 | 21,962 (Direct) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Mon, 17 Dec 2018 03:49:01 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |